Literature DB >> 8725795

Natural history study of pseudoachondroplasia.

J McKeand1, J Rotta, J T Hecht.   

Abstract

Pseudoachondroplasia (PSACH) is a well-characterized autosomal dominant dwarfing condition. A great deal of information is available about orthopedic complications, but little is known about extraskeletal complications in adulthood. This study was undertaken to delineate the natural history of PSACH at all ages. Seventy-nine individuals responded to an extensive questionnaire that included information about deformities, operations, general health, chronic diseases, and reproduction. PSACH individuals were ascertained through the University of Texas Medical Genetics patient population, a genetic linkage study, and the social organization, Little People of America. The results show that PSACH individuals with a family history do not have a distinct or more severe phenotype than new mutation cases. There were not differences in the number of orthopedic complications, operations, or number of offspring between these two groups. Less than half of affected adults reported having total hip replacement surgery, which was less common than previously reported. Extraskeletal complications were generally uncommon. There were four cases of cancers in 41 individuals queried. Premature osteoarthritis was the major health problem for PSACH individuals. PSACH individuals are generally healthy but have problems associated with debilitating osteoarthritis.

Entities:  

Mesh:

Year:  1996        PMID: 8725795     DOI: 10.1002/(SICI)1096-8628(19960517)63:2<406::AID-AJMG16>3.0.CO;2-O

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  33 in total

1.  Mutant cartilage oligomeric matrix protein (COMP) compromises bone integrity, joint function and the balance between adipogenesis and osteogenesis.

Authors:  Francoise Coustry; Karen L Posey; Tristan Maerz; Kevin Baker; Annie M Abraham; Catherine G Ambrose; Sabah Nobakhti; Sandra J Shefelbine; Xiaohong Bi; Michael Newton; Karissa Gawronski; Lindsay Remer; Alka C Veerisetty; Mohammad G Hossain; Frankie Chiu; Jacqueline T Hecht
Journal:  Matrix Biol       Date:  2018-01-05       Impact factor: 11.583

Review 2.  Novel therapeutic interventions for pseudoachondroplasia.

Authors:  Karen L Posey; Jacqueline T Hecht
Journal:  Bone       Date:  2017-03-21       Impact factor: 4.398

3.  Pseudoachondroplasia and the seven Ovitz siblings who survived Auschwitz.

Authors:  Oliver J Muensterer; Walter E Berdon; Ralph S Lachman; Stephen L Done
Journal:  Pediatr Radiol       Date:  2012-03-18

4.  Novel mTORC1 Mechanism Suggests Therapeutic Targets for COMPopathies.

Authors:  Karen L Posey; Francoise Coustry; Alka C Veerisetty; Mohammad G Hossain; Michael J Gambello; Jacqueline T Hecht
Journal:  Am J Pathol       Date:  2019-01       Impact factor: 4.307

Review 5.  Cartilage oligomeric matrix protein: COMPopathies and beyond.

Authors:  Karen L Posey; Francoise Coustry; Jacqueline T Hecht
Journal:  Matrix Biol       Date:  2018-03-09       Impact factor: 11.583

6.  Chop (Ddit3) is essential for D469del-COMP retention and cell death in chondrocytes in an inducible transgenic mouse model of pseudoachondroplasia.

Authors:  Karen L Posey; Francoise Coustry; Alka C Veerisetty; Peiman Liu; Joseph L Alcorn; Jacqueline T Hecht
Journal:  Am J Pathol       Date:  2011-12-07       Impact factor: 4.307

7.  D469del-COMP retention in chondrocytes stimulates caspase-independent necroptosis.

Authors:  Françoise Coustry; Karen L Posey; Peiman Liu; Joseph L Alcorn; Jacqueline T Hecht
Journal:  Am J Pathol       Date:  2011-12-07       Impact factor: 4.307

8.  Skeletal dysplasias associated with mild myopathy-a clinical and molecular review.

Authors:  Katarzyna A Piróg; Michael D Briggs
Journal:  J Biomed Biotechnol       Date:  2010-05-24

9.  An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype.

Authors:  Karen L Posey; Alka C Veerisetty; Pieman Liu; Huiqiu R Wang; Brian J Poindexter; Roger Bick; Joseph L Alcorn; Jacqueline T Hecht
Journal:  Am J Pathol       Date:  2009-09-17       Impact factor: 4.307

10.  Chondrocyte-specific pathology during skeletal growth and therapeutics in a murine model of pseudoachondroplasia.

Authors:  Karen L Posey; Francoise Coustry; Alka C Veerisetty; Peiman Liu; Joseph L Alcorn; Jacqueline T Hecht
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.